To say the Covid-19 vaccination wave in 2021 moved the needle for Pfizer (NYSE:PFE) stock is an understatement. Revenue nearly doubled thanks to its vaccine candidate (Comirnaty), which the pharma firm co-developed with BioNTech (NASDAQ:BNTX). PFE stock performed strongly as well during this timeframe. So far in 2022, however, Pfizer’s performance has been far less
Stocks to buy
Once considered to be a cash cow for investors, finding semiconductor stocks to buy and hold can be daunting these days. The iShares Semiconductor ETF (NASDAQ:SOXX), an exchange traded fund that holds 30 leading semiconductor stocks, is down more than 35% so far this year as a chip shortage continues to stress the industry. But if you’re a
With the recent surge in interest in virtual reality and other immersive technologies, it’s no surprise that investors are looking to get in on the action. One area that has seen a lot of excitement lately is metaverse stocks. The revolutionary new phenomenon can revolutionize how we interact with one another in the digital age,
Investors are still searching for a bottom in the stock market. We don’t know if it’s already in or if more pain is coming. What we do know is that there are stocks to buy in the meantime. Specifically, there are stocks to buy now before the market bottoms. There are plenty of high-quality, blue-chip stocks that
With Americans being an optimistic bunch, the general assumption that the equities sector will rise following the ugly year in 2022 fundamentally bolsters several stocks to buy. However, it’s important to be selective. You see, not every company might make it out of the long and dark tunnel we find ourselves in. And that’s largely
With the monetary paradigm shifting beneath our feet, investors have every reason to consider no-brainer dividend stocks to buy for 2023 and beyond. This is no marketing gimmick – folks need to avoid paralysis by analysis and direct their portfolios based on intuitive dynamics. That’s an overly complicated way of saying don’t fight the current
Lithium is crucial for the green energy boom. The only problem is that there’s more demand than there is supply, which isn’t likely to balance out any time soon. That alone should put these seven no-brainer lithium stocks at the top of your buy list. In fact, to keep up with demand, every existing producer
With macroeconomic trends becoming much more favorable and many growth stocks trading at depressed levels, there are several reasons to believe that growth stocks will soon rally. As a result, longer-term investors should look for growth stocks to buy at this point. Among the favorable macro trends are China’s reopening, impending U.S. government stimulus in
Cash is king. Cash lets companies grow through hard times, which is vital in technology. What investors forgot in 2022 is that tech has always been a boom-and-bust business. If you’re making computer chips or building clouds, you have enormous capital needs. You must invest through the business cycle. Cash is how you do it. So,
Apple (NASDAQ:AAPL) became the latest member of the FAANG-plus-Microsoft (NASDAQ:MSFT) group to deliver bad news on Nov. 6. Specifically, AAPL reported that shipments of its iPhone 14 Pro and iPhone 14 Pro Max would be below its previous outlook. The hardware giant blamed supply issues caused by Chinese anti-coronavirus measures for its miss, which strikes me
No-brainer battery stocks are a great choice for investors looking to cash in on the growing trends toward electric vehicles and renewable energy sources. These companies are leading the way in developing cutting-edge technologies, and things are looking good for their continued success in the future. Over the past few years, we have seen a
When the going gets tough, stick with reliable businesses. For a good example of this principle in action, consider how Apple (NASDAQ:AAPL) stock held up comparatively well during this harsh earnings season. Granted, some skeptics will observe that Apple isn’t planning to ramp up its hiring activity, but that’s not a reason to dismiss the tech
The 2022 midterm elections are all over except for the counting. Several key states are still tabulating their votes, but it does seem likely that the Republican Party will win back control of, at least, the House of Representatives. That means the country will have a divided government, which is historically good news for stocks.
One of the best growth investors of the past decade, Cathie Wood is often regarded as among the most underrated investors. She is incredibly growth-focused in her investment arguments, and presents interesting data to back up her surprisingly astute claims. Accordingly, many disregard her view that innovation means everything and valuations are less important, particularly
[embedded content] In our most recent episode of Hypergrowth Investing, we checked in with one of our favorites. SoFi (SOFI) is one of those stocks that checks every box. And for a while now, we’ve been bullish on SoFi’s growth velocity. Looking ahead to 2023, we’re even more bullish. The up-and-coming fintech company is truly
There need to be two billion electric vehicles on the road by 2050 for the world to hit net zero. Currently, there are 5.6 million electric vehicles globally. If the target for 2050 is to be achieved, current EV sales are just the tip of the iceberg. With a deep correction, it’s one of the best times to look
Discounted tech stocks to buy are plenty. The great tech wreck of 2022 is in stark contrast to the easy gains investors enjoyed between 2020-2021. With the pandemic, the associated lockdown, low interest rates, and the endless stimulus packages absent, tech stocks are at a multi-year discount. Speculators are no longer willing to bet on
[embedded content] Despite the macro picture, we’re confident that tech is our top investment option over the next few years. We’re looking at some mid- to large-cap tech stocks with great financials and sticky businesses that got grossly overvalued during the pandemic – but are now trading at some great discounts. And software stocks are
Despite best efforts to dissuade investors from seeking extremely speculative market ideas, the concept of penny stocks to buy continues to rank among popular search query items. Perhaps human nature is simply fascinated with macabre, which may explain why horror films generate much popularity. None of us want to experience truly terrifying events in real
It’s no exaggeration to say that Nov. 1 was the most important day of the entire year for pharmacy retailer CVS Health (NYSE:CVS). That’s because CVS stock shot higher as a result of a pair of notable news items. Not only did CVS Health finally reach a settlement involving thousands of lawsuits, but the company also